Psilocybin PTSD Treatment: Where the Research Stands in 2026
Psilocybin PTSD treatment is still investigational. The strongest evidence so far is a single small open-label trial of 22 people, which showed meaningful symptom reductions but...
Psychedelics and Trauma: How These Medicines Work at the Neurological Level
Psychedelics appear to address trauma by temporarily increasing the brain’s capacity to change, opening a window in which fear-based memories become editable rather than fixed. The...
The Best Psychedelic for PTSD? Comparing MDMA, Psilocybin, and Ketamine
MDMA-assisted therapy has the strongest evidence of any psychedelic for PTSD, with two completed Phase 3 trials showing that a majority of participants no longer met...
Complex PTSD Psychedelic Therapy: Why cPTSD Is Different from PTSD
Complex PTSD (cPTSD) differs from PTSD because it develops from prolonged, repeated trauma, and it adds lasting disturbances in emotional regulation, self-worth, and relationships on top...
PTSD Psychedelic Therapy: A Science-Based Overview
Among psychedelic approaches to PTSD, MDMA-assisted therapy has the strongest evidence, with two Phase 3 trials showing large symptom reductions, though the FDA declined to approve...
MDMA for Complex PTSD: Why Standard Treatments Fall Short
MDMA for complex PTSD has not been tested in a dedicated clinical trial, so no treatment can honestly claim proven results for this diagnosis. What we...
MDMA PTSD Therapy: Inside the Most Promising Psychedelic Research Ever Conducted
MDMA PTSD therapy produced the strongest results of any psychedelic research program to date. Across two Phase 3 trials, roughly seven in ten participants no longer...
Psychedelic Therapy for Anxiety Disorders: What the Research Shows
The strongest evidence for psychedelic therapy in anxiety disorders comes from trials treating anxiety tied to a life-threatening illness, where single doses of psilocybin or LSD...
Ketamine PTSD Treatment: What the Clinical Evidence Shows
Ketamine PTSD treatment has produced rapid symptom relief in small controlled trials, with some participants improving within hours rather than weeks. The evidence is promising but...
MDMA Therapy 2026 Update: Where Things Stand After the FDA Rejection
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD in August 2024, and as of mid-2026 that decision stands. MDMA remains a Schedule I...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.